Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Equinix Inc (EQIX) vs Tenet Healthcare Corporation (THC) Price & Performance

Equinix IncTrade
Tenet Healthcare CorporationTrade

Price performance (Past 24H)

Key statistics

Equinix Inc vs Tenet Healthcare Corporation — how do they compare? Equinix Inc trades at $1,033.5 (market cap $102.95B), while Tenet Healthcare Corporation trades at $260.39 (market cap $20.93B). The key difference: Equinix Inc is far larger — about 4.9× Tenet Healthcare Corporation's market cap, and Equinix Inc pays a 1.98% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.

EQIXTHC
Market Cap
$102.95B$20.93B
Sector
Real EstateHealth
52-Week High
$1.12K$262.63
52-Week Low
$726.09$161.37
Enterprise Value
$124.08B$32.01B
Dividend Yield
1.98%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Equinix Inc

Equinix (EQIX) trades at $1,042.62, down 0.97% on the day, with strong analyst support (74.5% buy ratings) and a consensus price target of $1,120. The stock shows bullish technical signals with support at $1,040 and resistance at $1,067. Recent Q2 2026 earnings beat expectations with $4.83 EPS versus $4.73 expected, while revenue growth continues at 9.2B in 2025 with improving net margins to 15.63%. The company maintains robust cash flow from operations at $3.9B despite significant capital investments.

EQIX presents a compelling growth story driven by AI infrastructure demand and global digital expansion, though elevated valuation multiples (P/E 67.09) and substantial debt levels ($15.2B total debt) warrant caution. The stock offers dividend income with recent $5.16 payments, but investors should monitor execution risks in capital-intensive expansion and competitive pressures in the data center REIT sector.

Tenet Healthcare Corporation

Tenet Healthcare (THC) trades at $262.13, up 2.14% with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with Q2 2026 EPS beating estimates at $6.12 versus $4.26 expected, while valuation metrics remain attractive with P/E of 10.05 and EV/EBITDA of 5.74. Recent institutional buying and positive earnings revisions support the upward trend.

Outlook remains positive with consensus price target of $281.44 offering 7.4% upside potential. Key risks include healthcare policy headwinds and competitive pressures, but strong ambulatory growth and expense management provide fundamental support. The stock presents a compelling value-growth combination for investors seeking healthcare exposure.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Equinix Inc

Equinix is a retail provider of data centers, enabling hundreds of enterprise tenants to house their servers and networking equipment in a collocated environment. Tenants can then connect with each other, through cloud service providers and telecom networks. Equinix operates 240 data centers in 66 markets worldwide and owns just less than half of them. The firm has roughly 10,000 customers, including 2,000 networks, that are dispersed over five verticals: Cloud and IT Services, Content Providers, Network and Mobile Services, Financial Services, and Enterprise. About 70% of Equinix's revenue comes from renting space to tenants and related services, and more than 15% comes from connecting customers with each other. Equinix operates as a real estate investment trust.

Read more on EQIX

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC